New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages

Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb...

Full description

Bibliographic Details
Main Authors: Kathrin Haake, Nico Lachmann
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671119304096
_version_ 1818333817025331200
author Kathrin Haake
Nico Lachmann
author_facet Kathrin Haake
Nico Lachmann
author_sort Kathrin Haake
collection DOAJ
description Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages. : Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages.
first_indexed 2024-12-13T13:57:39Z
format Article
id doaj.art-f9f4b810934e4331aa4f3bcd8e7189d0
institution Directory Open Access Journal
issn 2213-6711
language English
last_indexed 2024-12-13T13:57:39Z
publishDate 2019-12-01
publisher Elsevier
record_format Article
series Stem Cell Reports
spelling doaj.art-f9f4b810934e4331aa4f3bcd8e7189d02022-12-21T23:42:50ZengElsevierStem Cell Reports2213-67112019-12-01136957959New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived MacrophagesKathrin Haake0Nico Lachmann1Institute of Experimental Hematology, RG Translational Hematology of Congenital Diseases, Hannover Medical School, Hannover, Germany; REBIRTH – Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, GermanyInstitute of Experimental Hematology, RG Translational Hematology of Congenital Diseases, Hannover Medical School, Hannover, Germany; REBIRTH – Research Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, Germany; Corresponding authorInfections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages. : Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages.http://www.sciencedirect.com/science/article/pii/S2213671119304096
spellingShingle Kathrin Haake
Nico Lachmann
New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
Stem Cell Reports
title New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_full New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_fullStr New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_full_unstemmed New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_short New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
title_sort new drugs for an old foe mycobacterium tuberculosis meets psc derived macrophages
url http://www.sciencedirect.com/science/article/pii/S2213671119304096
work_keys_str_mv AT kathrinhaake newdrugsforanoldfoemycobacteriumtuberculosismeetspscderivedmacrophages
AT nicolachmann newdrugsforanoldfoemycobacteriumtuberculosismeetspscderivedmacrophages